Last year, there was a 15% annual increase in the operations and surgeons want more research.

Symptoms to look out for include severe pain in the stomach and back which does not go away.

With GLP-1 drugs rising in popularity, how are businesses adapting to a new type of consumer?

A two-year trial involving 300 people in Guernsey will look at the impact of weight loss jabs.

Dr Elise Dallas, GP at The London General Practice, explains how these medications impact our bodies and what happens after you stop taking them.

The UK's drug watchdog has urged anyone taking GLP-1 weight loss drugs to be 'aware and alert' of symptoms ...

The researchers are urging people to do one essential thing after shedding the pounds ...

Weight loss jab to launch stronger dosage as UK demand set to soar - The stronger Wegovy dose could see more than 20 per cent weight loss in patients with obesity ...

How weight-loss jabs are changing the way we spend money - Around 2.5 million people are currently estimated to be on ...

Lighter passengers means less fuel.

Half of UK GPs are seeing children under seven with obesity - 80 per cent of GPs said they find it challenging to talk to the ...

The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds - The impacts of weight-loss medications reach far beyond the realm of health and wellness ...